Tangier disease: Still more questions than answers

Cellular and Molecular Life Sciences

Volumn 62, Issue 19-20, 2005, Pages 2150-2160

  Nofer, J R ^a   Remaley, A T ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Arteriosclerosis; ATP binding cassette transporter 1 (ABCA1); Cholesterol efflux; High density lipoprotein (HDL); Reverse cholesterol transport; Tangier disease

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; HORMONE RECEPTOR STIMULATING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER X RECEPTOR AGONIST; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; GENE EXPRESSION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MUTATION; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TANGIER DISEASE;

ATP-BINDING CASSETTE TRANSPORTERS; CARDIOVASCULAR DISEASES; HUMANS; LIPOPROTEINS, HDL; PHENOTYPE; TANGIER DISEASE;

EID: 27144475012     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-005-5125-0     Document Type: Review

References (105)

1. Fredrickson D. S., Altrocchi P. H., Avioli L. V., Goodman D. S. and Goodman H. C. (1961) Tangier disease: combined clinical staff conference at the National Institute of Health. Ann. Int. Med. 55: 1016-1030
2. Brown M. S. and Goldstein J. L. (1976) Familial hypercholesterolemia: a genetic defect in the low-density lipoprotein receptor. N. Engl. J. Med. 294: 1386-1390
3. Kannel W. B., Castelli W. P., Gordon T. and McNamara P. M. (1971) Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann. Intern. Med. 74: 1-12
4. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B. and Dawber T. R. (1977) High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med. 62: 707-714
5. Glomset J. (1968) The plasma lecithin:cholesterol acyltransferase reaction. J. Lipid Res. 9: 155
6. Ho Y. K., Brown M. S. and Goldstein J. L. (1980) Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoprotein and other agents. J. Lipid Res. 21: 391-398
7. Rothblat G. H., Llera-Moya M. de la, Atger V., Kellner-Weibel G., Williams D. L. and Phillips M. C. (1999) Cell cholesterol efflux: integration of old and new observations provides new insights. J. Lipid Res. 40: 781-796
8. Schmitz G., Assmann G., Rall S. C. Jr and Mahley R. W. (1983) Tangier disease: defective recombination of a specific Tangier apolipoprolein A-I isoform (pro-apo A-I) with high density lipoproteins. Proc. Natl. Acad. Sci. USA 80: 6081-6085
9. Bojanovski D., Gregg R. E. and Brewer H. B. Jr (1984) Tangier disease: in vitro conversion of proapo-A-I(Tangier) to mature APO-A-I(Tangier). J. Biol. Chem. 259: 6049-6051
10. Law S. W. and Brewer H. B. Jr (1985) Tangier disease: the complete mRNA sequence encoding for preproapo-A-I. J. Biol. Chem. 260: 12810-12814
11. Biesbroeck R., Oram J. F., Albers J. J. and Bierman E. L. (1983) Specific high-affinity binding of high density lipoproteins to cultured human skin fibroblasts and arterial smooth muscle cells. J. Clin. Invest. 71: 525-539
12. Oram J. F., Brinton E. A. and Bierman E. L. (1983) Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells. J. Clin. Invest. 72: 1611-1621
13. Fidge N. H. (1999) High density lipoprotein receptors, binding proteins, and ligands. J. Lipid Res. 40: 187-201
14. Koller E., Koller F. and Binder B. R. (1989) Purification and identification of the lipoprotein-binding proteins from human blood platelet membrane. J. Biol. Chem. 264: 12412-12418
15. Chiu D. S., Oram J. F., LeBoeuf R. C., Alpers C. E. and O'Brien K. D. (1997) High-density lipoprotein-binding protein (HBP)/vigilin is expressed in human atherosclerotic lesions and colocalizes with apolipoprotein E. Arterioscler. Thromb. Vasc. Biol. 17: 2350-2358
16. Matsumoto A., Mitchell A., Kurata H., Pyle L., Kondo K., Itakura H. et al. (1997) Cloning and characterization of HB2, a candidate high density lipoprotein receptor: sequence homology with members of the immunoglobulin superfamily of membrane proteins. J. Biol. Chem. 272: 16778-16782
17. Acton S., Rigotti A., Landschulz K. T., Xu S., Hobbs H. H. and Krieger M. (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271: 518-520
18. Drobnik W., Mollers C., Resink T. and Schmitz G. (1995) Activation of phosphatidylinositol-specific phospholipase C in response to HDL3 and LDL is markedly reduced in cultured fibroblasts from Tangier patients. Arterioscler. Thromb. Vasc. Biol. 15: 1369-1377
19. Walter M., Reinecke H., Gerdes U., Nofer J. R., Hobbel G., Seedorf U. et al. (1996) Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease: evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms. J. Clin. Invest. 98: 2315-2323
20. Drobnik W., Liebisch G., Biederer C., Trümbach B., Rogler G., Muller P. et al. (1999) Growth and cell cycle abnormalities of fibroblasts from Tangier disease patients. Arterioscler. Thromb. Vasc. Biol. 19: 28-38
21. Huang Y., Eckardstein A. von, Wu S., Langer C. and Assmann G. (1995) Generation of pre-beta 1-HDL and conversion into alpha-HDL: evidence for disturbed HDL conversion in Tangier disease. Arterioscler. Thromb. Vasc. Biol. 15: 1746-1754
22. Davidson W. S., Sparks D. L., Lund-Katz S. and Phillips M. C. (1994) The molecular basis for the difference in charge between pre-beta- and alpha-migrating high density lipoproteins. J. Biol. Chem. 269: 8959-8965
23. Eckardstein A. von, Chirazi A., Schuler-Luttmann S., Walter M., Kastelein J. J., Geisel J. et al. (1998) Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I. J. Lipid Res. 39: 987-998
24. Walter M., Gerdes U., Seedorf U. and Assmann G. (1994) The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects. Biochem. Biophys. Res. Commun. 205: 850-856
25. Rogler G., Trumbach B., Klima B., Lackner K. J. and Schmitz G. (1995) HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. Arterioscler Thromb. Vasc. Biol. 15: 683-690.
26. Francis G. A., Knopp R. H. and Oram J. F. (1995) Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J. Clin. Invest. 96: 78-87
27. Remaley A. T., Schumacher U. K., Stonik J. A., Farsi B. D., Nazih H. and Brewer H. B. Jr (1997) Decreased reverse cholesterol transport from Tangier disease fibroblasts: acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler. Thromb. Vasc. Biol. 17: 1813-1821
28. Hara H. and Yokoyama S. (1991) Interaction of free apolipoproteins with macrophages: formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J. Biol. Chem. 266: 3080-3086
29. Bojanovski D., Gregg R. E., Zech L. A., Meng M. S., Bishop C., Ronan R. et al. (1987) In vivo metabolism of proapolipoprotein A-I in Tangier disease. J. Clin. Invest. 80: 1742-1747
30. Rust S., Walter M., Funke H., Eckardstein A. von, Cullen P., Kroes H. Y. et al. (1998) Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy. Nat. Genet. 20: 96-98
31. Rust S., Rosier M., Funke H., Real J., Amoura Z., Piette J. C. et al. (1999) Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22: 352-355
32. Bodzioch M., Orso E., Klucken J., Langmann T., Bottcher A., Diederich W. et al. (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22: 347-351
33. Brooks-Wilson A., Marcil M., Clee S. M., Zhang L. H., Roomp K., van Dam M. et al. (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22: 336-345
34. Luciani M. F., Denizot F., Savary S., Mattei M. G. and Chimini G. (1994) Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics 21: 150-159
35. Langmann T., Klucken J., Reil M., Liebisch G., Luciani M. F., Chimini G. et al. (1999) Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 257: 29-33
36. Remaley A. T., Rust S., Rosier M., Knapper C., Naudin L., Broccardo C. et al. (1999) Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc. Natl. Acad. Sci. USA 96: 12685-12690
37. Jones P. M. and George A. M. (2004) The ABC transporter structure and mechanism: perspectives on recent research. Cell. Mol. Life Sci. 61: 682-699
38. Borst P. and Elferink R. O. (2002) Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 71: 537-592
39. Knight B. L. (2004) ATP-binding cassette transporter A1: regulation of cholesterol efflux. Biochem. Soc. Trans. 32: 124-127
40. Broccardo C., Luciani M. and Chimini G. (1999) The ABCA subclass of mammalian transporters. Biochim. Biophys. Acta 1461: 395-404
41. Wang N., Silver D. L., Thiele C. and Tall A. R. (2001) ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J. Biol. Chem. 276: 23742-23747
42. Fielding P. E., Nagao K., Hakamata H., Chimini G. and Fielding C. J. (2003) A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1. Biochemistry 39: 14113-14120
43. Zha X., Genest J. Jr and McPherson R. (2001) Endocytosis is enhanced in Tangier fibroblasts: possible role of ATP-binding cassette protein Al in endosomal vesicular transport. J. Biol. Chem. 276: 39476-39483
44. Mendez A. J., Lin G., Wade D. P., Lawn R. M. and Oram J. F. (2001) Membrane lipid domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated lipid secretory pathway. J. Biol. Chem. 276: 3158-3166
45. Drobnik W., Borsukova H., Bottcher A., Pfeiffer A., Liebisch G., Schutz G. J. et al. (2002) Apo AI/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains. Traffic 3: 268-278
46. Hamon Y., Broccardo C., Chambenoit O., Luciani M. F., Toti F., Chaslin S. et al. (2000) ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat. Cell Biol. 2: 399-406
47. Chambenoit O., Hamon Y., Marguet D., Rigneault H., Rosseneu M. and Chimini G. (2001) Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter. J. Biol. Chem. 276: 9955-9960
48. Smith J. D., Waelde C., Horwitz A. and Zheng P. (2002) Evaluation of the role of phosphatidylserine translocase activity in ABCA1-mediated lipid efflux. J. Biol. Chem. 277: 17797-17803
49. Oram J. F., Lawn R. M., Garvin M. R. and Wade D. P. (2000) ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 275: 34508-34511
50. Wang N., Silver D. L., Costet P. and Tall A. R. (2000) Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J. Biol. Chem. 275: 33053-33058
51. Wu C. A., Tsujita M., Hayashi M. and Yokoyama S. (2004) Probucol inactivates ABCA1 in the plasma membrane with respect to its mediation of apolipoprotein binding and high density lipoprotein assembly and to its proteolytic degradation. J. Biol. Chem. 279: 30168-30174
52. Fitzgerald M. L., Mendez A. J., Moore K. J., Andersson L. P., Panjeton H. A. and Freeman M. W. (2001) ATP-binding cassette transporter A1 contains an NH2-terminal signal anchor sequence that translocates the protein's first hydrophilic domain to the exoplasmic space. J. Biol. Chem. 276: 15137-15145
53. Bungert S., Molday L. L. and Molday R. S. (2001) Membrane topology of the ATP binding cassette transporter ABCR and its relationship to ABC1 and related ABCA transporters: identification of N-linked glycosylation sites. J. Biol. Chem. 276: 23539-23546
54. Fitzgerald M. L., Morris A. L., Chroni A., Mendez A. J., Zannis V. I. and Freeman M. W. (2004) ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux. J. Lipid Res. 45: 287-294
55. Chroni A., Liu T., Gorshkova I., Kan H. Y., Uehara Y., Eckardstein A. von et al. (2003) The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux: amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo. J. Biol. Chem. 278: 6719-6730
56. Chroni A., Liu T., Fitzgerald M. L., Freeman M. W. and Zannis V. I. (2004) Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1. Biochemistry 43: 2126-2139
57. Natarajan P., Forte T. M., Chu B., Phillips M. C., Oram J. F. and Bielicki J. K. (2004) Identification of an apolipoprotein A-I structural element that mediates cellular cholesterol efflux and stabilizes ATP binding cassette transporter A1. J. Biol. Chem. 279: 24044-24052
58. Remaley A. T., Stonik J. A., Demosky S. J., Neufeld E. B., Bocharov A. V., Vishnyakova T. G. et al. (2001) Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem. Biophys. Res. Commun. 280: 818-823
59. Remaley A. T., Thomas F., Stonik J. A., Demosky S. J., Bark S. E., Neufeld E. B. et al. (2003) Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway. J. Lipid Res. 44: 828-836
60. Denis M., Haidar B., Marcil M., Bouvier M., Krimbou L. and Genest J. Jr (2004) Molecular and cellular physiology of apolipoprotein A-I lipidation by the ATP-binding cassette transporter A1 (ABCA1). J. Biol. Chem. 279: 7384-7394
61. Tang C., Vaughan A. M. and Oram J. F. (2004) Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol. J. Biol. Chem. 279: 7622-7628
62. Buechler C., Boettcher A., Bared S. M., Probst M. C. and Schmitz G. (2002) The carboxyterminus of the ATP-binding cassette transporter Al interacts with a beta2-syntrophin/utrophin complex. Biochem. Biophys. Res. Commun. 293: 759-765
63. Munehira Y., Ohnishi T., Kawamoto S., Furuya A., Shitara K., Imamura M. et al. (2004) Alpha1-syntrophin modulates turnover of ABCA1. J. Biol. Chem. 279: 15091-15095
64. Tsukamoto K., Hirano K., Tsujii K., Ikegami C., Zhongyan Z., Nishida Y. et al. (2001) ATP-binding cassette transporter-1 induces rearrangement of actin cytoskeletons possibly through Cdc42/N-WASP. Biochem. Biophys. Res. Commun. 287: 757-765
65. Bortnick A. E., Rothblat G. H., Stoudt G., Hoppe K. L., Royer L. J., McNeish J. et al. (2000) The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J. Biol. Chem. 275: 28634-28640
66. Denis M., Haidar B., Marcil M., Bouvier M., Krimbou L. and Genest J. (2004) Characterization of oligomeric human ATP binding cassette transporter Al: potential implications for determining the structure of nascent high density lipoprotein particles J. Biol. Chem. 279: 41529-41536
67. Tsujita M., Wu C. A., Abe-Dohmae S., Usui S., Okazaki M. and Yokoyama S. (2005) On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway. J. Lipid Res. 46: 154-162
68. Sahoo D., Trischuk T. C., Chan T., Drover V. A., Ho S., Chimini G. et al. (2004) ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes. J. Lipid Res. 45: 1122-1131
69. Kiss R. S., McManus D. C., Franklin V., Tan W. L., McKenzie A., Chimini G. et al. (2003) The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and-independent pathways. J. Biol. Chem. 278: 10119-10127
70. Vaisman B. L., Lambert G., Amar M., Joyce C., Ito T., Shamburek R. D. et al. (2001) ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. J. Clin. Invest. 108: 303-309
71. Singaraja R. R., Bocher V., James E. R., Clee S. M., Zhang L. H., Leavitt B. R. et al. (2001) Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. J. Biol. Chem. 276: 33969-33979
72. Basso F., Freeman L., Knapper C. L., Remaley A., Stonik J., Neufeld E. B. et al. (2003) Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations. J. Lipid Res. 44: 296-302
73. Wellington C. L., Brunham L. R., Zhou S., Singaraja R. R., Visscher H., Gelfer A. et al. (2003) Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1. J. Lipid Res. 44: 1470-1480
74. Timmins J. M., Lee J. Y., Boudygina E., Kluckman K. D., Brunham L. R., Mulya A. et al. (2005) Targeted inactivation of hepatic ABCA1 causes profound hypoaphalipoproteinemia and kidney hypercatabolism of apo A-I. J. Clin. Invest. 115: 1333-1342
75. Hayden M. R. (2005) Tissue specific of ABCA1 to HDL biogenesis. VI Annual Conference on Arteriosclerosis, Thrombosis, and Vascular Biology, Washington, April 28-30
76. Aiello R. J., Brees D., Bourassa P. A., Royer L., Lindsey S., Coskran T. et al. (2002) Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler. Thromb. Vasc. Biol. 22: 630-637
77. Haghpassand M., Bourassa P. A., Francone O. L. and Aiello R. J. (2001) Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J. Clin. Invest. 108: 1315-1320
78. Eck M. van, Bos I. S., Kaminski W. E., Orso E., Rothe G., Twisk J. et al. (2002) Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc. Natl. Acad. Sci. USA 99: 6298-6303
79. McNeish J., Aiello R. J., Guyot D., Turi T., Gabel C., Aldinger C. et al. (2000) High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc. Natl. Acad. Sci. USA 97: 4245-4250
80. Wang N., Lan D., Gerbod-Giannone M., Linsel-Nitschke P., Jehle A. W., Chen W. et al. (2003) ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux. J. Biol. Chem. 278: 42906-42912
81. Abe-Dohmae S., Ikeda Y., Matsuo M., Hayashi M., Okuhira K., Ueda K. et al. (2004) Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein. J. Biol. Chem. 279: 604-611
82. Linsel-Nitschke P., Jehle A. W., Shan J., Cao G., Bacic D., Lan D. et al. (2005) Potential role of ABCA7 in cellular lipid efflux to apoA-I. J. Lipid Res. 46: 86-92
83. Kim W. S., Fitzgerald M. L., Kang K., Okuhira K., Bell S. A., Manning J. J. et al. (2005) AbcA7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels. J. Biol. Chem. 280: 3989-3995
84. Wang N., Lan D., Chen W., Matsuura F. and Tall A. R. (2004) ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. USA 101: 9774-9779
85. Cavelier L. B., Qiu Y., Bielicki J. K., Afzal V., Cheng J. F. and Rubin E. M. (2001) Regulation and activity of the human ABCA1 gene in transgenic mice. J. Biol. Chem. 276: 18046-18051
86. Joyce C. W., Amar M. J., Lambert G., Vaisman B. L., Paigen B., Najib-Fruchart J. et al. (2002) The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc. Natl. Acad. Sci. USA 99: 407-412
87. Oram J. F., Vaughan A. M. and Stocker R. (2001) ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol. J. Biol. Chem. 276: 39898-39902
88. Koldamova R. P., Lefterov I. M., Ikonomovic M. D., Skoko J., Lefterov P. I., Isanski B. A. et al. (2003) 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. J. Biol. Chem. 278: 13244
89. Chen Z. J., Vulevic B., Ile K. E., Soulika A., Davis W. Jr, Reiner P. B. et al. (2001) ATP-binding cassette transporter ABC2/ABCA2 in the rat brain: a novel mammalian lysosome-associated membrane protein and a specific marker for oligodendrocytes but not for myelin sheaths. J. Neurosci. 21: 849-857
90. Zhou C., Zhao L., Inagaki N., Guan J., Nakajo S., Hirabayashi T. et al. (2004) Association of ABCA2 expression with determinants of Alzheimer's disease. FASEB J. 18: 1129-1131
91. Osborne T. F. (1997) Cholesterol homeostasis: clipping out a slippery regulator. Curr. Biol. 7: R172-R174
92. Costet P., Luo Y., Wang N. and Tall A. R. (2000) Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 275: 28240-28245
93. Jaye M. (2003) LXR agonists for the treatment of atherosclerosis. Curr. Opin. Invest. Drugs 4: 1053-1058
94. Repa J. J., Turley S. D., Lobaccaro J. A., Medina J., Li L., Lustig K. et al. (2001) Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289: 1524-1529
95. Repa J. J., Liang G., Ou J., Bashmakov Y., Lobaccaro J. M., Shimomura I. et al. (2000) Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14: 2819-2830
96. Grefhorst A., Elzinga B. M., Voshol P. J., Plosch T., Kok T., Bloks V. W. et al. (2001) Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J. Biol. Chem. 277: 34182-34190
97. Miao B., Zondlo S., Gibbs S., Cromley D., Hosagrahara V. P., Kirchgessner T. G. et al. (2002) Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator. J. Lipid Res. 45: 1410-1417
98. Nissen S. E., Tsunoda T., Tuzcu E. M., Schoenhagen P., Cooper C. J., Yasin M. et al. (2003) Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290: 2292-2300
99. Newton R. S. and Krause B. R. (2002) HDL therapy for the acute treatment of atherosclerosis. Atheroscler. Suppl. 3: 31-38
100. Chiesa G. and Sirtori C. R. (2003) Recombinant apolipoprotein A-I(Milano): a novel agent for the induction of regression of atherosclerotic plaques. Ann. Med. 35: 267-273
101. Van Lenten B. J., Navab M., Shih D., Fogelman A. M., Lusis A. J. (2001) The role of high-density lipoproteins in oxidation and inflammation. Trends Cardiovasc. Med. 11: 155-161
102. Barter P. J., Nicholls S., Rye K. A., Anantharamaiah G. M., Navab M. and Fogelman A. M. (2004) Antiinflammatory properties of HDL. Circ. Res. 95: 764-772
103. Van Lenten B. J., Wagner A. C., Navab M., Anantharamaiah G. M., Hui E. K., Nayak D. P. et al. (2004) D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes. Circulation 110: 3252-3258
104. Navab M., Anantharamaiah G. M., Hama S., Garber D. W., Chaddha M., Hough G. et al. (2002) Oral administration of an Apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation 105: 290-292
105. Navab M., Anantharamaiah G. M., Reddy S. T., Van Lenten B. J., Datta G., Garber D. et al. (2004) Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal. Curr. Opin. Lipidol. 15: 645-649